Google Alert - Ebola

	Ebola As-it-happens update ⋅ May 1, 2020
	NEWS
	This is how remdesivir, developed for Hepatitis C and Ebola, fights Covid-19 ThePrint This is how remdesivir, developed for Hepatitis C and Ebola, fights Covid-19. The experimental antiviral drug that was developed by US pharmaceutical ... Flag as irrelevant
	Seven things you need to know about remdesivir – the Ebola drug that's 'helped Covid patients ... The Sun Remdesivir is an experimental antiviral drug produced by the US pharmaceutical company Gilead, initially as a potential treatment for Ebola. Flag as irrelevant
	OPINION: Rebuilding a more resilient planet Thomson Reuters Foundation Ebola has a mortality rate of around 50%. What if the next pandemic has a similar mortality rate and is as contagious as COVID-19? As a global ... Flag as irrelevant
	The Week in impact investing: Mobilization ImpactAlpha How Liberia and Sierra Leone rebounded after Ebola. When lenders returned to the West African countries in 2015 after the months-long shutdown ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback